Skip to main content

Table 5 Risk factors associated with maternal anaemia

From: Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine–pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso

Variable N Anaemia (%) Adjusted OR (95% CI)a P value
 Lafiabougou 43 33 (76.7) 1  
 Kua 58 31 (53.5) 0.35 (0.14–0.84) 0.018
  1. aMultivariable analysis using logistic regression adjusted for age, gravidity, education, use of IPTp-SP, parasite density, and Pfdhfr intermediate-to-high resistance